Skip to content

Cardiovascular Group, Inc.

Country not established

Devices
1

What Cardiovascular Group, Inc. makes

Cardiovascular Group, Inc. manufactures the POLY-TAC, a vascular stent designed for coronary and peripheral artery applications to restore blood flow in occluded or narrowed vessels.

The POLY-TAC is classified as a Class II medical device under FDA regulations and is authorised via the 510(k) clearance process. The company is based in the United States.

AI-generated from registry data, 2 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

  • Poly-Tac Ref K882235

    Active Regimes: 510(k) Registry: 510(k) Class:II

Frequently asked questions

How many devices does Cardiovascular Group, Inc. have in the registry?

The registry currently lists 1 device for Cardiovascular Group, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Cardiovascular Group, Inc.'s devices?

Among its 1 most recently registered device, Cardiovascular Group, Inc. has devices listed in FDA 510(k) (1 device).

What risk classes do Cardiovascular Group, Inc.'s devices fall under?

Among its 1 most recently registered device, the classes recorded for Cardiovascular Group, Inc.'s devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Cardiovascular Group, Inc. in the registry?

The most recently registered devices listed for Cardiovascular Group, Inc. include POLY-TAC.

Generated automatically from registry data and not verified by a human reviewer.